CG
EBS icon

Colony Group’s Emergent Biosolutions EBS Stock Holding History

Colony Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-28,735
Closed -$1.44M – 811
2021
Q3 		$1.44M Buy
28,735
+122
+0.4% +$7.39K 0.03% 361
2021
Q2 		$1.8M Buy
28,613
+413
+1% +$26.5K 0.04% 309
2021
Q1 		$2.62M Buy
28,200
+1,950
+7% +$200K 0.06% 268
2020
Q4 		$2.35M Buy
26,250
+4,714
+22% +$433K 0.05% 259
2020
Q3 		$2.23M Sell
21,536
-5,773
-21% -$622K 0.06% 251
2020
Q2 		$2.16M Sell
27,309
-499
-2% -$37.2K 0.06% 240
2020
Q1 		$1.61M Sell
27,808
-1,560
-5% -$89.9K 0.05% 270
2019
Q4 		$1.58M Sell
29,368
-425
-1% -$23.1K 0.04% 327
2019
Q3 		$1.56M Sell
29,793
-97
-0.3% -$4.52K 0.05% 299
2019
Q2 		$1.44M Buy
29,890
+65
+0.2% +$3.12K 0.05% 318
2019
Q1 		$1.51M Sell
29,825
-1,785
-6% -$105K 0.06% 242
2018
Q4 		$1.87M Sell
31,610
-895
-3% -$57.7K 0.09% 189
2018
Q3 		$2.14M Sell
32,505
-263
-0.8% -$15.3K 0.11% 174
2018
Q2 		$1.65M Sell
32,768
-65
-0.2% -$3.39K 0.09% 217
2018
Q1 		$1.73M Buy
32,833
+950
+3% +$47.3K 0.09% 208
2017
Q4 		$1.48M Buy
+31,883
New +$1.34M 0.09% 212

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Colony Group's EBS Position: Q4 2021 in Review

Colony Group sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 28,735 shares — an estimated $1.44M sold.

Colony Group first reported a position in EBS in Q4 2017 and held it in 16 quarters. The position peaked at $2.62M in Q1 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Colony Group reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • Colony Group sold 28,735 Emergent Biosolutions shares in Q4 2021, an estimated $1.44M.
  • Colony Group first reported a position in Emergent Biosolutions in Q4 2017 and held it in 16 quarters.
  • Colony Group's Emergent Biosolutions position peaked at $2.62M in Q1 2021.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Colony Group's 13F filing for Q4 2021, filed 15 Feb 2022.